Company intelligence / Profile preview

Kyocera

Ownership: Public · 6971
Employees: ~83001
Development stage: Other

Overview

Kyocera offers commercialized orthopedic joint replacements and dental implants using advanced ceramics/metals. Its SAW biosensor enables rapid point-of-care testing from urine/saliva samples. The company also provides cell separation/counting devices to support life sciences R&D. U.S. FDA clearance was obtained for artificial hip joints sold since at least 2017. No clinical trial data typical of drug development.

Therapeutic areas: RheumatologyOther
Modalities: DeviceImplantable deviceDiagnostic deviceCell separation technology/device
Industry: Implantable Medical Devices

Partnerships

Health Care Systems CorporationRenovis Surgical

Beyond the preview

Go deeper on Kyocera.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kyocera.

Explore the full profile